Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients

Detalles Bibliográficos
Autores principales: Destras, Grégory, Bal, Antonin, Simon, Bruno, Lina, Bruno, Josset, Laurence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142137/
https://www.ncbi.nlm.nih.gov/pubmed/35636438
http://dx.doi.org/10.1016/S2666-5247(22)00120-3
_version_ 1784715508074938368
author Destras, Grégory
Bal, Antonin
Simon, Bruno
Lina, Bruno
Josset, Laurence
author_facet Destras, Grégory
Bal, Antonin
Simon, Bruno
Lina, Bruno
Josset, Laurence
author_sort Destras, Grégory
collection PubMed
description
format Online
Article
Text
id pubmed-9142137
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Author(s). Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-91421372022-05-31 Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients Destras, Grégory Bal, Antonin Simon, Bruno Lina, Bruno Josset, Laurence Lancet Microbe Correspondence The Author(s). Published by Elsevier Ltd. 2022-08 2022-05-27 /pmc/articles/PMC9142137/ /pubmed/35636438 http://dx.doi.org/10.1016/S2666-5247(22)00120-3 Text en © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the BY-NC-ND 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Destras, Grégory
Bal, Antonin
Simon, Bruno
Lina, Bruno
Josset, Laurence
Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
title Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
title_full Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
title_fullStr Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
title_full_unstemmed Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
title_short Sotrovimab drives SARS-CoV-2 omicron variant evolution in immunocompromised patients
title_sort sotrovimab drives sars-cov-2 omicron variant evolution in immunocompromised patients
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142137/
https://www.ncbi.nlm.nih.gov/pubmed/35636438
http://dx.doi.org/10.1016/S2666-5247(22)00120-3
work_keys_str_mv AT destrasgregory sotrovimabdrivessarscov2omicronvariantevolutioninimmunocompromisedpatients
AT balantonin sotrovimabdrivessarscov2omicronvariantevolutioninimmunocompromisedpatients
AT simonbruno sotrovimabdrivessarscov2omicronvariantevolutioninimmunocompromisedpatients
AT linabruno sotrovimabdrivessarscov2omicronvariantevolutioninimmunocompromisedpatients
AT jossetlaurence sotrovimabdrivessarscov2omicronvariantevolutioninimmunocompromisedpatients

Ejemplares similares